Namita Chatterjee

436 citations
12 papers · 356 indexed · h-index 10
Topics
MicroRNA in disease regulation (7 papers)Histone Deacetylase Inhibitors Research (3 papers)Circular RNAs in diseases (3 papers)
Partner nations
United StatesGermany

In The Last Decade

Namita Chatterjee

11 papers receiving 350 citations

Peers

Namita Chatterjee
Comparison fields: 5 of 65
  • Molecular Biology 235
  • Cancer Research 160
  • Oncology 97
  • Immunology 55
  • Pathology and Forensic Medicine 36
Replace Yingxia Ning with:
Yingxia Ning China
Fang Cui China
Faying Xu China
Shu‐Chun Lin Taiwan
Jeannette Huaman United States
Elodie Ristorcelli France
Xianjun Zhu China
Ivaylo Stoimenov Sweden
Apple Long United States
Namita Chatterjee relative to Yingxia Ning China Yingxia Ning's profile →
Citations per field
00.5×
Yingxia Ning · 1×
Citations per year

Countries citing papers authored by Namita Chatterjee

Since Specialization
Citations

This map shows the geographic impact of Namita Chatterjee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Namita Chatterjee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Namita Chatterjee more than expected).

Fields of papers citing papers by Namita Chatterjee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Namita Chatterjee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Namita Chatterjee. The network helps show where Namita Chatterjee may publish in the future.

Co-authorship network of co-authors of Namita Chatterjee

This figure shows the co-authorship network connecting the top 25 collaborators of Namita Chatterjee. A scholar is included among the top collaborators of Namita Chatterjee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Namita Chatterjee. Namita Chatterjee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
#WorkIndexed citations
1 10
2 21
3 25
4 18
5
MicroRNA regulation of endothelial TREX1 reprograms the tumour microenvironment
18
6 51
7 7
8 12
9 36
10 98
11 60
12 0

About Namita Chatterjee

Namita Chatterjee is a scholar working on Cancer Research, Behavioral Neuroscience and Molecular Biology, having authored 12 papers that have together received 356 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (7 papers), Histone Deacetylase Inhibitors Research (3 papers) and Circular RNAs in diseases (3 papers). The work is most often cited by research in Cancer Research (160 citations), Oncology (97 citations) and Molecular Biology (235 citations). Namita Chatterjee has collaborated with scholars based in United States and Germany. Frequent co-authors include Martin Tenniswood, Sridar V. Chittur, JoEllen Welsh, Cristina Espinosa‐Díez, Louise Flanagan, Sudarshan Anand, Rebecca Ruhl, Shushan Rana, Christina Hipfinger and Omar F. Khan. Their work appears in journals such as Nature, Nature Communications and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026